Vall d'Hebron Talks by VHIR 'Genome Editing in Biomedicine in 2023'

 Vall d'Hebron Talks by VHIR
  Activitat Online —
01/10/2024
01/10/2024 -- From 11:00h to 12:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: Online
Share it:
Genome Editing in Biomedicine in 2023

Online seminar organized by Dr. Josep Quer within Translational Biomedical Research Master’s Degree’s Module 1, Transversal Skills for Translational Research in Human Pathology.

Speaker: Dr. Lluis Montoliu, PhD, Research Scientist CSIC -Centro Nacional de Biotecnologia (CNB)

🕚 11 a.m. – 12h p.m.

      Access here

Related activities

Fundamentos fisiopatológicos de la hipoxia tisular y monitorización del aporte cerebral de oxígeno

09/30/2024 - 09:00
Facultativos especialistas, residentes y personal de enfermería interesados ​​en el manejo del paciente neurocrítico
More information

II Curso CARE ME

10/03/2024 - 08:45
Cardiología y Nefrología
More information

Curso Oxigenación por Membrana Extracorpórea Pediátrica y Neonatal ECMOPedVH

10/08/2024 - 08:30
More information

Curso de especialista en gestión administrativa de Ensayos Clínicos (CTA)

Activitad Online
10/10/2024 - 10:00
More information

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.